Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2420)	10/13/2009 10:04:08 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CGEN opened with an UG but it is still below its Aug 27 H of $3.37 <g> Volume of >200,000 is already above its ADV. bigcharts.marketwatch.com It announced today that they have signed a collaboration agreement with Bayer covering the further evaluation of a CGEN discovered tumor target and its splice variants. The agreement provides Bayer with an option for an exclusive worldwide royalty bearing license for development of monoclonal antibodies and other therapeutic agents addressing these novel target molecules,following an initial 6 month joint research. There is no ACAY, but pending further news, I am going to place a temporary target at the Feb 2005 H of $6.54 <g> bigcharts.marketwatch.com Bernard